Cures 2.0 Would Mandate More FDA Centers of Excellence But Oncology-Style Funding Gaps Could Doom Plan

 
• By Sarah Karlin-Smith

The two new intercenter institutes, one to focus on a common group of diseases and the other on rare diseases, appear to be unfunded mandates, which could hinder the agency’s ability to get them up and running.

empty wallet
Congress may require FDA establish new Centers of Excellence without any corresponding new funding. • Source: Alamy

More from US FDA

More from Agency Leadership